T2 Biosystems (0A57) Income Statement
T2 Biosystems Income Statement
Last quarter (Q3 2024), T2 Biosystems's total revenue was $1.99M, an increase of 34.85% from the same quarter last year. In Q3, T2 Biosystems's net income was $-10.12M. See T2 Biosystems’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| $ 7.19M | $ 22.30M | $ 28.06M | $ 18.13M | $ 8.34M | |
| $ -8.17M | $ 1.17M | $ 7.36M | $ -3.15M | $ -8.43M | |
| $ 41.49M | $ 56.68M | $ 50.33M | $ 38.21M | $ 43.63M | |
| Depreciation and Amortization | $ 859.00K | $ 1.05M | $ 2.54M | $ 3.16M | $ 3.64M |
| $ -43.88M | $ -54.87M | $ -41.13M | $ -36.71M | $ -48.30M | |
| $ -49.66M | $ -54.05M | $ -42.97M | $ -41.36M | $ -52.06M | |
| $ -413.00K | $ -6.81M | $ -6.27M | $ -5.44M | $ -6.95M | |
| $ -50.08M | $ -62.00M | $ -49.24M | $ -46.80M | $ -59.01M | |
| $ -50.08M | $ -62.00M | $ -49.24M | $ -46.80M | $ -59.01M | |
| Per Share Metrics | |||||
| Basic EPS | $ -19.19 | $ -1222.14 | $ -1549.82 | $ -1928.54 | $ -6934.20 |
| Diluted EPS | $ -19.19 | $ -1222.14 | $ -1549.82 | $ -1928.54 | $ -6934.20 |
| Weighted Average Shares Outstanding | 2.61M | 51.00K | 31.77K | 24.27K | 9.10K |
| Weighted Average Shares Outstanding (Diluted) | 2.61M | 51.00K | 31.77K | 24.27K | 9.10K |
Currency in USD
